Sees Q3 revenue $614M-$636M, consensus $628.09M. Sees Q3 adjusted EBITDA $56M-$70M. “We believe virtual care can be a performance multiplier to help address key challenges in an evolving healthcare landscape. We intend to build on our leadership position by delivering and orchestrating care across patients, providers, platforms, and partners, enhancing the patient experience, improving clinical outcomes, and driving greater value for our clients,” Divita added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc reports Q2 EPS (19c), consensus (31c)
- Teladoc options imply 9.9% move in share price post-earnings
- Carvana upgraded, Ulta Beauty downgraded: Wall Street’s top analyst calls
- Teladoc initiated with a Neutral at Mizuho
- Teladoc’s Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment